181 related articles for article (PubMed ID: 24092501)
1. Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.
Vyas AR; Singh SV
Eur J Nutr; 2014 Apr; 53(3):843-52. PubMed ID: 24092501
[TBL] [Abstract][Full Text] [Related]
2. The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.
Hahm ER; Singh KB; Kim SH; Powolny AA; Singh SV
Cancer Prev Res (Phila); 2020 Aug; 13(8):661-672. PubMed ID: 32434809
[TBL] [Abstract][Full Text] [Related]
3. Notch activation is dispensable for D, L-sulforaphane-mediated inhibition of human prostate cancer cell migration.
Hahm ER; Chandra-Kuntal K; Desai D; Amin S; Singh SV
PLoS One; 2012; 7(9):e44957. PubMed ID: 22970326
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of phenethyl isothiocyanate treatment on vimentin protein expression in cancer cells.
Sakao K; Hahm ER; Singh SV
Nutr Cancer; 2013; 65 Suppl 1(0 1):61-7. PubMed ID: 23682784
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention.
Beaver LM; Buchanan A; Sokolowski EI; Riscoe AN; Wong CP; Chang JH; Löhr CV; Williams DE; Dashwood RH; Ho E
Mol Nutr Food Res; 2014 Oct; 58(10):2001-13. PubMed ID: 25044704
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells.
Sakao K; Vyas AR; Chinni SR; Amjad AI; Parikh R; Singh SV
Cancer Prev Res (Phila); 2015 May; 8(5):365-74. PubMed ID: 25712054
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.
Hahm ER; Singh SV
Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
Singh KB; Kim SH; Hahm ER; Pore SK; Jacobs BL; Singh SV
Carcinogenesis; 2018 May; 39(6):826-837. PubMed ID: 29668854
[TBL] [Abstract][Full Text] [Related]
9. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.
Choi S; Lew KL; Xiao H; Herman-Antosiewicz A; Xiao D; Brown CK; Singh SV
Carcinogenesis; 2007 Jan; 28(1):151-62. PubMed ID: 16920735
[TBL] [Abstract][Full Text] [Related]
10. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
Herman-Antosiewicz A; Xiao H; Lew KL; Singh SV
Mol Cancer Ther; 2007 May; 6(5):1673-81. PubMed ID: 17513615
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagy.
Vyas AR; Hahm ER; Arlotti JA; Watkins S; Stolz DB; Desai D; Amin S; Singh SV
Cancer Res; 2013 Oct; 73(19):5985-95. PubMed ID: 23921360
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.
Tian H; Zhou Y; Yang G; Geng Y; Wu S; Hu Y; Lin K; Wu W
Oncol Rep; 2016 Sep; 36(3):1361-8. PubMed ID: 27430422
[TBL] [Abstract][Full Text] [Related]
14. Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane.
Singh KB; Hahm ER; Alumkal JJ; Foley LM; Hitchens TK; Shiva SS; Parikh RA; Jacobs BL; Singh SV
Carcinogenesis; 2019 Dec; 40(12):1545-1556. PubMed ID: 31555797
[TBL] [Abstract][Full Text] [Related]
15. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling.
Chen X; Jiang Z; Zhou C; Chen K; Li X; Wang Z; Wu Z; Ma J; Ma Q; Duan W
Cell Physiol Biochem; 2018; 50(3):1201-1215. PubMed ID: 30355942
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
17. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells.
Cho SD; Li G; Hu H; Jiang C; Kang KS; Lee YS; Kim SH; Lu J
Nutr Cancer; 2005; 52(2):213-24. PubMed ID: 16201852
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo.
Singh AV; Xiao D; Lew KL; Dhir R; Singh SV
Carcinogenesis; 2004 Jan; 25(1):83-90. PubMed ID: 14514658
[TBL] [Abstract][Full Text] [Related]
19. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.
Kim SH; Singh SV
Mol Cancer Ther; 2009 Jul; 8(7):1946-54. PubMed ID: 19584240
[TBL] [Abstract][Full Text] [Related]
20. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW
Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
